Irinotecan in Treating Children With Refractory or Progressive Solid Tumors
Part of paid clinical trials in Houston, Texas.
- Sponsor
- Texas Children's Cancer Center
- Study ID
- NCT00016861
- Phase
- PHASE1
- Status
- Completed
Conditions
- Unspecified Childhood Solid Tumor, Protocol Specific
Eligibility Criteria
- Sex
- ALL
- Age
- 1 Year - 21 Years
- Healthy Volunteers
- Not accepted
Interventions
- irinotecan hydrochloride — DRUG
Study Details
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of irinotecan in treating children who have refractory or progressive solid tumors.
Key Dates
- Start date
- Sep 30, 1998
- Status verified
- Nov 2004
- Completion
- Jan 31, 2005
Study Design
- Primary purpose
- TREATMENT
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Texas Children's Cancer Center | Houston | Texas | 77030-2399 | - |
Find similar trials in Houston, TX
By research site
Related Studies
- Collection and Storage of Tissue Samples From Patients Undergoing Surgery For Suspected Solid TumorsRecruiting · Wake Forest University Health Sciences · Winston-Salem, North Carolina